Record overview
Status and phase
Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1, PHASE2
Sponsor: Erasca, Inc.
Condition: Advanced or Metastatic Solid Tumors
NCT04866134
A Study of ERAS-007 as Monotherapy or in Combination With ERAS-601 in Patients With Advanced or Metastatic Solid Tumors
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: long_recruitment_duration_signal
Results signal: Low Signal
Operational burden: large_enrollment_target_signal | rare_population_signal
Stopped reason
Context when available
No stop reason available in the current public record.